Terms: = Brain cancer AND MEN1, ENSG00000133895, 4221 AND Treatment
51 results:
1. Use of pembrolizumab among older adults with cancer in the United States, before and after FDA approval of its tumor-agnostic indication.
Hong YD; Enewold L; Halpern MT; Zeruto C; Mariotto AB
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5745. PubMed ID: 38156547
[TBL] [Abstract] [Full Text] [Related]
2. Genetic Testing in Hereditary Pituitary Tumors.
Akkuş G; Korbonits M
Arch Med Res; 2023 Dec; 54(8):102920. PubMed ID: 38007383
[TBL] [Abstract] [Full Text] [Related]
3. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract] [Full Text] [Related]
4. Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
[TBL] [Abstract] [Full Text] [Related]
5. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
[TBL] [Abstract] [Full Text] [Related]
6. Pediatric growth hormone and prolactin-secreting tumor associated with an
Alexandre MI; Faria CC; Gomes A; Bugalho MJ
J Pediatr Endocrinol Metab; 2023 Feb; 36(2):199-202. PubMed ID: 36597712
[TBL] [Abstract] [Full Text] [Related]
7. Rare clinical manifestation of multiple endocrine neoplasia type 1.
Petriczko E; Marcinkiewicz K; Prokurat A; Sagan L; Malkowski B; Biczysko-Mokosa A; Horodnicka-Jozwa A; Andrysiak-Mamos E; Syrenicz A; Kostrzeba E; Walczak M
Neuro Endocrinol Lett; 2022 Nov; 43(4):199-207. PubMed ID: 36528881
[TBL] [Abstract] [Full Text] [Related]
8. Giant prolactinoma in children and adolescents: a single-center experience and systematic review.
Kumar S; Sarathi V; Lila AR; Sehemby M; Memon SS; Karlekar M; Sankhe S; Patil VA; Shah N; Bandgar T
Pituitary; 2022 Dec; 25(6):819-830. PubMed ID: 35851929
[TBL] [Abstract] [Full Text] [Related]
9. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract] [Full Text] [Related]
10. Pituitary adenoma in patients with multiple endocrine neoplasia type 1: a cohort study.
Le Bras M; Leclerc H; Rousseau O; Goudet P; Cuny T; Castinetti F; Bauters C; Chanson P; Tabarin A; Gaujoux S; Christin-Maitre S; Ruszniewski P; Borson-Chazot F; Guilhem I; Caron P; Goichot B; Beckers A; Delemer B; Raingeard I; Vergès B; Smati S; Wargny M; Cariou B; Hadjadj S
Eur J Endocrinol; 2021 Nov; 185(6):863-873. PubMed ID: 34636744
[TBL] [Abstract] [Full Text] [Related]
11. Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
Dolina J; Kunovsky L; Kroupa R; Stary K; Jabandziev P; Nesporova T; Maca K; Andrasina T; Marek F; Kala Z; Vaculova J; Said D; Zapletalova M; Lochman J; Palova Noskova H; Slaby O; Izakovicova Holla L; Borilova Linhartova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):228-235. PubMed ID: 34282806
[TBL] [Abstract] [Full Text] [Related]
12. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: a case report and literature review.
Shi S; Zhang L; Yu Y; Wang C; Li J
BMC Endocr Disord; 2021 May; 21(1):90. PubMed ID: 33933067
[TBL] [Abstract] [Full Text] [Related]
13. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical and genetic studies of a three-member familial isolated pituitary adenoma with homogeneous prolactinomas].
Vacchiano V; Seleme S; Daly AF; Beckers A; Valdés-Socin H
Medicina (B Aires); 2020; 80(2):181-184. PubMed ID: 32282328
[TBL] [Abstract] [Full Text] [Related]
15. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract] [Full Text] [Related]
16. Aggressive pituitary tumors in the young and elderly.
Tatsi C; Stratakis CA
Rev Endocr Metab Disord; 2020 Jun; 21(2):213-223. PubMed ID: 31912365
[TBL] [Abstract] [Full Text] [Related]
17. [Multiple endocrine neoplasia type 1: about a case].
Anguezomo G; El Mghari G; El Ansari N
Pan Afr Med J; 2019; 33():238. PubMed ID: 31692695
[TBL] [Abstract] [Full Text] [Related]
18. Pituitary tumours in men1 syndrome - the new insight into the diagnosis and treatment.
Rogoziński D; Gilis-Januszewska A; Skalniak A; Kluczyński Ł; Pantofliński J; Hubalewska-Dydejczyk A
Endokrynol Pol; 2019; 70(5):445-452. PubMed ID: 31681967
[TBL] [Abstract] [Full Text] [Related]
19. The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma.
Zhu H; Miao Y; Shen Y; Guo J; Xie W; Zhao S; Dong W; Zhang Y; Li C
J Transl Med; 2019 Oct; 17(1):354. PubMed ID: 31665029
[TBL] [Abstract] [Full Text] [Related]
20. Genetics of Pituitary Tumours.
Loughrey PB; Korbonits M
Exp Suppl; 2019; 111():171-211. PubMed ID: 31588533
[TBL] [Abstract] [Full Text] [Related]
[Next]